Overview
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Indication
For the treatment of human immunovirus (HIV) infections.
Associated Conditions
- Human Immunodeficiency Virus (HIV) Infections
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2016/02/02 | Phase 3 | Completed | Willem Daniel Francois Venter | ||
2014/09/25 | Phase 2 | Completed | |||
2012/05/18 | Phase 4 | Terminated | University of Witwatersrand, South Africa | ||
2010/06/22 | Phase 3 | Completed | |||
2008/02/18 | Phase 4 | Completed | Peking Union Medical College | ||
2007/09/14 | Phase 3 | Completed | |||
2006/06/21 | Phase 4 | Completed | |||
2006/04/07 | Phase 1 | Completed | |||
2005/11/21 | Not Applicable | Completed | CIPRA SA | ||
2005/10/10 | Phase 4 | UNKNOWN | Groupe Hospitalier Pitie-Salpetriere |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
State of Florida DOH Central Pharmacy | 53808-0594 | ORAL | 40 mg in 1 1 | 6/8/2010 | |
State of Florida DOH Central Pharmacy | 53808-0795 | ORAL | 40 mg in 1 1 | 8/12/2010 | |
State of Florida DOH Central Pharmacy | 53808-0656 | ORAL | 20 mg in 1 1 | 8/12/2010 | |
State of Florida DOH Central Pharmacy | 53808-0595 | ORAL | 40 mg in 1 1 | 6/8/2010 | |
Cipla Ltd. | 53104-0111 | ORAL | 1 mg in 1 mL | 1/16/2019 | |
State of Florida DOH Central Pharmacy | 53808-0657 | ORAL | 30 mg in 1 1 | 8/12/2010 | |
State of Florida DOH Central Pharmacy | 53808-0852 | ORAL | 20 mg in 1 1 | 9/30/2013 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
STAVUDINE CAPSULES 40MG | N/A | i & c (hong kong) limited | N/A | N/A | 8/25/2014 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
ZERIT - CAP 20MG | bristol-myers squibb canada | 02216094 | Capsule - Oral | 20 MG | 7/30/1996 |
ZERIT - CAP 15MG | bristol-myers squibb canada | 02216086 | Capsule - Oral | 15 MG | 7/30/1996 |
ZERIT | bristol-myers squibb canada | 02237009 | Powder For Solution - Oral | 1 MG / ML | N/A |
ZERIT - CAP 40MG | bristol-myers squibb canada | 02216116 | Capsule - Oral | 40 MG | 7/30/1996 |
ZERIT - CAP 30MG | bristol-myers squibb canada | 02216108 | Capsule - Oral | 30 MG | 7/30/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
ZERIT 20 mg CAPSULA DURA | 96009004 | CÁPSULA DURA | Uso Hospitalario | Not Commercialized | |
ZERIT 30 mg CAPSULA DURA | 96009006 | CÁPSULA DURA | Uso Hospitalario | Not Commercialized | |
ZERIT 40 mg CAPSULA DURA | 96009008 | CÁPSULA DURA | Uso Hospitalario | Not Commercialized | |
ZERIT 200 mg POLVO PARA SOLUCION ORAL | 96009009 | POLVO PARA SOLUCIÓN ORAL | Uso Hospitalario | Not Commercialized | |
ZERIT 15 mg CAPSULA DURA | 96009002 | CÁPSULA DURA | Uso Hospitalario | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.